Herzig M - Search Results

1

Base excision repair, aging and health span.

Xu G, Herzig M, Rotrekl V, Walter CA. Xu G, et al. Among authors: herzig m. Mech Ageing Dev. 2008 Jul-Aug;129(7-8):366-82. doi: 10.1016/j.mad.2008.03.001. Epub 2008 Mar 13. Mech Ageing Dev. 2008. PMID: 18423806 Free PMC article. Review.

2

Perfluorocarbons cause thrombocytopenia, changes in RBC morphology and death in a baboon model of systemic inflammation.

Pidcoke HF, Delacruz W, Herzig MC, Schaffer BS, Leazer ST, Fedyk CG, Montogomery RK, Prat NJ, Parida BK, Aden JK, Scherer MR, Reddick RL, Shade RE, Cap AP. Pidcoke HF, et al. PLoS One. 2022 Dec 30;17(12):e0279694. doi: 10.1371/journal.pone.0279694. eCollection 2022. PLoS One. 2022. PMID: 36584001 Free PMC article.

3

Human O6 -methylguanine-DNA methyltransferase containing C145A does not prevent hepatocellular carcinoma in C3HeB/FeJ transgenic mice.

Herzig MC, Hildreth K, Huamani J, Perez M, Goins BA, McMahan CA, Reddick RL, Walter CA. Herzig MC, et al. Mol Carcinog. 2013 Apr;52(4):275-85. doi: 10.1002/mc.21855. Epub 2011 Dec 27. Mol Carcinog. 2013. PMID: 22213062

4

TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.

Mu X, Lin S, Yang J, Chen C, Chen Y, Herzig MC, Washburn K, Halff GA, Walter CA, Sun B, Sun LZ. Mu X, et al. PLoS One. 2013 May 21;8(5):e63436. doi: 10.1371/journal.pone.0063436. Print 2013. PLoS One. 2013. PMID: 23704908 Free PMC article.

5

DNA Alkylating Agent Protects Against Spontaneous Hepatocellular Carcinoma Regardless of O6-Methylguanine-DNA Methyltransferase Status.

Herzig MC, Zavadil JA, Street K, Hildreth K, Drinkwater NR, Reddick T, Herbert DC, Hanes MA, McMahan CA, Reddick RL, Walter CA. Herzig MC, et al. Cancer Prev Res (Phila). 2016 Mar;9(3):245-52. doi: 10.1158/1940-6207.CAPR-15-0251. Epub 2015 Dec 14. Cancer Prev Res (Phila). 2016. PMID: 26667451 Free PMC article.

6

C3HeB/FeJ Mice mimic many aspects of gene expression and pathobiological features of human hepatocellular carcinoma.

Zavadil JA, Herzig MCS, Hildreth K, Foroushani A, Boswell W, Walter R, Reddick R, White H, Zare H, Walter CA. Zavadil JA, et al. Mol Carcinog. 2019 Mar;58(3):309-320. doi: 10.1002/mc.22929. Epub 2018 Nov 25. Mol Carcinog. 2019. PMID: 30365185

7

Apoptosis induction by the dual-action DNA- and protein-reactive antitumor drug irofulven is largely Bcl-2-independent.

Herzig MC, Trevino AV, Liang H, Salinas R, Waters SJ, MacDonald JR, Woynarowska BA, Woynarowski JM. Herzig MC, et al. Biochem Pharmacol. 2003 Feb 15;65(4):503-13. doi: 10.1016/s0006-2952(02)01552-6. Biochem Pharmacol. 2003. PMID: 12566077

8

Oxaliplatin-induced damage of cellular DNA.

Woynarowski JM, Faivre S, Herzig MC, Arnett B, Chapman WG, Trevino AV, Raymond E, Chaney SG, Vaisman A, Varchenko M, Juniewicz PE. Woynarowski JM, et al. Among authors: herzig mc. Mol Pharmacol. 2000 Nov;58(5):920-7. doi: 10.1124/mol.58.5.920. Mol Pharmacol. 2000. PMID: 11040038

9

The genome factor in region-specific DNA damage: the DNA-reactive drug U-78779 prefers mixed A/T-G/C sequences at the nucleotide level but is region-specific for long pure AT islands at the genomic level.

Herzig MC, Rodriguez KA, Trevino AV, Dziegielewski J, Arnett B, Hurley L, Woynarowski JM. Herzig MC, et al. Biochemistry. 2002 Feb 5;41(5):1545-55. doi: 10.1021/bi011907s. Biochemistry. 2002. PMID: 11814348

10

Irofulven induces apoptosis in breast cancer cells regardless of caspase-3 status.

Herzig MC, Liang H, Johnson AE, Woynarowska B, Woynarowski JM. Herzig MC, et al. Breast Cancer Res Treat. 2002 Jan;71(2):133-43. doi: 10.1023/a:1013855615712. Breast Cancer Res Treat. 2002. PMID: 11883439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page